Little is known about treatment outcomes for children who have end-stage renal disease (ESRD) after treatment for Wilms tumor (WT).
Time-to-transplant, graft failure, and survival outcomes were examined for 173 children enrolled on the National Wilms Tumor Study who developed ESRD.
Fifty-five patients whose ESRD resulted from progressive bilateral WT (PBWT) experienced high early mortality from WT that limited their opportunity for transplant (47% at 5 years) and survival (44% at 10 years) in comparison to population controls. The 118 patients whose ESRD was due to other causes (termed “chronic kidney disease”), many of whom had WT-associated congenital anomalies, had transplant (77% at 5 years) and survival (73% at 10 years) outcomes no worse than those for population controls. Graft failure following transplant was comparable for the two groups. Minority children had twice the median time to transplant as non-Hispanic whites and twice the mortality rates, also reflecting population trends.
In view of the continuing high mortality in patients with ESRD, and the dramatic improvement in outlook following kidney transplantation, re-evaluation of current guidelines for a 2-year delay in transplant following WT treatment may be warranted.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Ehrlich PF (2007) Wilms tumor: progress and considerations for the surgeon. Surg Oncol 16:157–171
Dome JS, Perlman EJ, Ritchey ML, Coppes MJ, Kalapurakal JA, Grundy PE (2005) Renal tumors. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 5th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 905–932
Smith MA, Seibel NL, Altekruse SF, Ries LAG, Melbert DL, O'Leary M, Smith FO, Reaman GH (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28:2625–2634
Groothoff JW (2005) Long-term outcomes of children with end-stage renal disease. Pediatr Nephrol 20:849–853
Shapiro R, Sarwal MM (2010) Pediatric kidney transplantation. Pediatr Clin N Am 57:393–400
Demaria JE, Hardy BE, Brezinski A, Churchill BM (1979) Renal transplantation in patients with bilateral Wilms tumor. J Pediatr Surg 14:577–579
Penn I (1979) Renal transplantation for Wilms tumor—report of 20 cases. J Urol 122:793–794
EBPG Expert Group (2002) SECTION IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 17:1–67
Nankivell BJ, Kuypers DRJ (2011) Organ transplantation 3 diagnosis and prevention of chronic kidney allograft loss. Lancet 378:1428–1437
Geissler EK (2010) Can immunosuppressive strategies be used to reduce cancer risk in renal transplant patients? Transplant Proc 42:S32–S35
McDonald SP, Craig JC (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654–2662
Foster BJ, Dahhou M, Zhang X, Platt RW, Hanley JA (2011) Change in mortality risk over time in young kidney transplant recipients. Am J Transplant 11:2432–2442
Rudin C, Pritchard J, Fernando ON, Duffy PG, Trompeter RS (1998) Renal transplantation in the management of bilateral Wilms tumour (BWT) and of Denys–Drash syndrome (DDS). Nephrol Dial Transplant 13:1506–1510
Kist-van Holthe JE, Ho PL, Stablein D, Harmon WE, Baum MA (2005) Outcome of renal transplantation for Wilms tumor and Denys–Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 9:305–310
Lange J, Peterson SM, Takashima JR, Grigoriev YA, Ritchey ML, Shamberger RC, Beckwith JB, Perlman E, Green DM, Breslow NE (2011) Risk factors for end-stage renal disease in non-WT1-syndromic Wilms tumor. J Urol 186:378–386
US Renal Data System (2009) USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, pp 1–421
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:456–481
Peto R, Peto J (1972) Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185–206
Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc B 34:187–220
Woodroofe M (1985) Estimating a distribution function with truncated data. Ann Stat 13:163–177
Crowley J, Hu M (1977) Covariance analysis of heart transplant survival data. J Am Stat Assoc 72:27–36
Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706
R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
US Renal Data System (2010) Pediatric ESRD. USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, pp 325–334
Stolzmann KL, Bautista LE, Gangnon RE, McElroy JA, Becker BN, Remington PL (2007) Trends in kidney transplantation rates and disparities. J Natl Med Assoc 99:923–932
Gadegbeku C, Freeman M, Agodoa L (2002) Racial disparities in renal replacement therapy. J Natl Med Assoc 94:45S–54S
US Renal Data System (2009) Morbidity and mortality. USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, pp 269–280
Beckwith JB, Palmer NF (1978) Histopathology and prognosis of Wilms tumor. Cancer 41:1937–1948
Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901
This study was supported in part by grant CA054498 from the United States National Cancer Institute. We thank investigators of the Children’s Oncology Group and the health professionals who managed the care of children entered in the National Wilms Tumor Study.
About this article
Cite this article
Grigoriev, Y., Lange, J., Peterson, S.M. et al. Treatments and outcomes for end-stage renal disease following Wilms tumor. Pediatr Nephrol 27, 1325–1333 (2012). https://doi.org/10.1007/s00467-012-2140-x